HMOX1 and cancer: Recent study showed that HO1 acted as an immune checkpoint molecule in myeloid cell and a combination therapy of SnMP with 5‐FU boosted anti‐tumor immune response in breast tumor model.[17] As previously described before,[17] many kinds of chemotherapeutics induce anti‐cancer immune responses.